← FDA DRUG APPROVALS

FDA NDA · NDA009268

CHOLEDYL

Sponsor: PARKE DAVIS

APPLICATION
NDA009268
TYPE
NDA
ROUTE
ORAL
DOSAGE FORM
SOLUTION, TABLET, DELAYED RELEASE, SYRUP
MARKETING STATUS
Discontinued

Products

CHOLEDYLDiscontinued
OXTRIPHYLLINE 100MG/5ML · SOLUTION · ORAL
CHOLEDYLDiscontinued
OXTRIPHYLLINE 200MG · TABLET, DELAYED RELEASE · ORAL
CHOLEDYLDiscontinued
OXTRIPHYLLINE 50MG/5ML · SYRUP · ORAL
CHOLEDYLDiscontinued
OXTRIPHYLLINE 100MG · TABLET, DELAYED RELEASE · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →